Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Oxaliplatin 7Fluorouracil 6Leucovorin 5Bevacizumab 4Watchful Waiting 3Capecitabine 3XELOX 2Neoadjuvant Therapy 2Irinotecan 2Indocyanine Green 2Chemotherapy, Adjuvant 2Cetuximab 2sulindac sulfone 1pembrolizumab 1encorafenib 1dehydroftorafur 1cyclopropapyrroloindole 1Tranexamic Acid 1Standard of Care 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Panitumumab 1Observation 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Iohexol 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Colonic Neoplasms × cyclopropapyrroloindole × Clear all
NCT03755739 2024-06-25

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Second Affiliated Hospital of Guangzhou Medical University

Phase 2/3 Recruiting
200 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡